USANA Health Sciences down 16.8% after RSI falls below 30 threshold
USANA Health Sciences shares have fallen 16.8% over the past four weeks, reaching an RSI of 29.62, signaling oversold conditions. Consensus EPS estimates for the current year have risen 2.6% over the last 30 days and USANA ranks in the top 5% of over 4,000 stocks for earnings estimate revisions.
1. Recent Share Performance
USANA Health Sciences shares have declined 16.8% over the past four weeks following sustained selling pressure, positioning the stock well below its recent trading range.
2. Technical Oversold Signal
The stock’s Relative Strength Index stands at 29.62, with readings below 30 commonly interpreted as oversold and potentially primed for a bullish reversal.
3. Fundamental Estimate Revisions
Consensus EPS estimates for the current fiscal year have increased by 2.6% over the past 30 days, placing USANA in the top 5% of more than 4,000 stocks based on earnings estimate trends.
4. Potential Rebound Outlook
The combination of oversold technical readings and upward earnings revisions suggests a possible near-term rebound, though RSI limitations warrant consideration of additional indicators before making investment decisions.